25 results about "Cannabis substance" patented technology

Aseptic product processing systems and methods may include a hopper for introducing the product into the system and one or more components through which the product flows as it is processed, an enclosure surrounding one or more of the components, a gassing assembly comprising a plurality of gassing elements to maintain a substantially constant flow of inert gas over the product as it travels through the system components, and a filtered gas recirculation system that recirculates air or filtered gas through the enclosure. Such systems may be particularly advantageous for use in the cannabis industry.

Compositions including Δ-9-tetrahydrocannabinol (THC) and a carbonic andydrase inhibitor and methods of using these compositions for the treatment of obstructive sleep apnoea (OSA). The treatment method also includes administering dronabinol and acetazolaminde and combinations thereof to a subject in need thereof.

Abstract: A biodegradable polymer composi on, according to the present inven on, comprises polyhydroxybutyrate and poly(3- hydroxybutyrate-co-3-hydroxyhexanoate) blended with thermoplas c starch, one or more compa bilizers selected from the group consis ng of dihexyl sodium sulfosuccinate and maleic anhydride, and one or more addi ves selected from the group consis ng of microcrystalline cellulose and cellulose. Methods of producing a biodegradable polymer use processed cannabis waste as a carbon source. Abstract:

Compositions comprising 0.1-50 % delta-9-tetrahydrocannabinol and / or cannabidiol in forms suitable for continuous delivery and use thereof in the treatment of a variety of diseases and pathological disorders are disclosed. In preferred embodiments, the compositions are in a form suitable for delivery via a portable infusion pump or transdermal patch. The disorders to be treated include pain, cancer, seizure disorders, and Parkinson's disease. Depending on the disorder to be treated, the compositions may optionally further comprise additional active agents such as dopaminergic agents.

The present invention provides a novel room-temperature extraction system and method for cannabis and hemp, utilizing custom membrane filtration to efficiently isolate cannabinoids, terpenes, and other bioactive compounds while reducing energy consumption. This multi-stage system begins with a custom milling machine that preprocesses biomass by separating non-target components, such as cellulose-rich stalks, to improve extraction efficiency. The core extraction process employs a series of custom membranes designed to selectively filter cannabinoids and terpenes, minimizing impurities without the need for traditional sub-zero cooling. Each membrane stage incorporates solvent recovery to recycle ethanol, reducing waste and operational costs. In the final stage, a custom concentrator removes residual ethanol, decarboxylates THCa to THC, and crystallizes sugars to prevent downstream clogging. This room-temperature extraction system significantly enhances yield, purity, and sustainability, making it a scalable and cost-effective solution for cannabis and hemp processing industries, as well as applicable for pharmaceutical and nutraceutical uses.

The present invention relates to the use of cannabidiol (CBD) in the treatment of patients with childhood-onset epilepsy who are concurrently taking caffeine. Where the CBD is used in combination with caffeine, caution should be taken. For example, the dose of either the CBD and / or caffeine may be required to be reduced. Moreover, the patient may need to be monitored for side effects of said drug-drug interaction. Preferably the CBD used is in the form of a highly purified extract of cannabis such that the CBD is present at greater than 95% of the total extract (w / w) and the other components of the extract are characterised. In particular the cannabinoid tetrahydrocannabinol (THC) has been substantially removed, to a level of not more than 0.15% (w / w) and the propyl analogue of CBD, cannabidivarin, (CBDV) is present in amounts of up to 1%. Alternatively, the CBD may be a synthetically produced CBD.

A mechanism for monitoring cannabis and predicting or determining a harvesting time. A sensing arrangement generates a temporal sequence of VOC values, each representing a measured amount of a first set of one or more volatile organic compounds (VOCs) in the air surrounding some cannabis. This temporal sequence is then processed to determine a harvesting time, at which the cannabis is ready for harvesting (e.g., meets some predetermined criteria for achieving a harvesting goal).

This invention provides methods for the synthesis of cannabidiol and its analogues, as well as related compounds, formulations, and methods of use. [Solution] Methods are provided for the synthesis of oliveitol, oliveitol analogs, cannabidiol (CBD), CBD analogs, and other cannabinoids. One method uses phloroglucinol or phloroglucinol analogs as starting materials. The synthesis is stereospecific, efficient, selective, cost-effective, and THC((-)-trans-Δ 9 There is little to no possibility of generating (tetrahydro-cannabinol) or any other psychoactive by-products. Shortened synthesis is also provided, as well as new cannabinoids, pharmaceutical formulations, and methods of use.

The invention provides compositions and methods for selecting and achieving desired effects from cannabinoid emulsions. This is achieved by adjusting components of the composition, including fats, emulsifiers, and cannabinoids.

An antimicrobial illumination system utilizes non- ultraviolet (non-UV) visible light, centered around 405 nm, to inhibit bacteria, fungi, mold, and yeast on stored food, cannabis, and healthcare products. Metal-clad printed circuit boards (MCPCBs ) of various geometries embed the LEDs and are integrated into lids, countertops, tabletops, and storage enclosures. The system provides continuous or intermittent antimicrobial illumination that is safe in occupied environments and preserves product quality without UV-induced degradation.The MCPCB integrates antimicrobial functionality, structural support, and thermal management in a single unit suitable for food, cannabis, and healthcare storage, as well as cosmetic and therapeutic uses.

The present application relates to compositions comprising avocado / soybean unsaponifiables (“ASU”) and cannabis, and related methods of use. In one embodiment, the cannabis is a cannabis oil extract that is combined with ASU to reduce inflammatory responses and inflammation in humans and animals.

A refrigeration system for a cannabis product manufacturing machine provided with an intrant feeding system includes i) an enclosure for receiving at least part of the cannabis product manufacturing machine and having at least one opening for allowing access to the intrant feeding system and to cannabis products after production; and ii) a refrigeration system operatively mounted to the enclosure for forcing a first temperature in the enclosure. The refrigeration system can also be provided with a refrigeration subsystem coupled to the intrant feeding system for forcing a second temperature therein.

Described herein are methods, compositions, products, and processes that utilize bioceramics in traditional agricultural and hydroponic systems. The bioceramics are utilized in powder form, as films, as aerosols, as water based treatment systems, or in solid forms. The methods and bioceramic compositions described here are also used for growing a Cannabis plant. One or more cannabinoids within the plant can be used in therapeutic compositions for the treatment of glaucoma, AIDS wasting syndrome, neuropathic pain, cancer, multiple sclerosis, chemotherapy-induced nausea, and certain seizure disorders.

The present invention relates to: a method for producing a genome-edited hemp plant having an increased cannabidiol (CBD) content and a decreased delta-9-tetrahydrocannabinol (THC) content by editing a hemp-derived cannabis sativa delta-9-tetrahydrocannabinolic acid synthase (CsTHCAS) gene; and a genome-edited hemp plant having an increased CBD content and a decreased THC content produced by said method. The production method according to the present invention increases the content of CBD, which is the effective ingredient of hemp, and decreases the content of THC, which is an addictive psychoactive ingredient, and thus can be effectively used in the development of novel varieties of medicinal hemp.

This invention relates to aerosol generation for the delivery of cannabis components, derivatives, or extracts. [Solution] An aerosol-generating composition is provided, comprising a first aerosol-generating material containing an active substance which is a component, derivative, or extract of cannabis and a gelling agent, and a second aerosol-generating material which contains a different active substance and a gelling agent. In some embodiments, the first, second and / or further aerosol-generating materials comprise about 15 to about 70% by weight of an active substance, about 10 to about 50% by weight of an aerosol-forming material, about 15 to about 60% by weight of a gelling agent, and optionally a filler, where the weight percentage values ​​are calculated on a dry weight basis. Products comprising the composition and methods for preparing the composition are also provided.

This utility model relates to the field of agricultural production technology, specifically a convenient hemp harvesting device, comprising: a protective shell, a connecting base fixedly connected to the lower end of the protective shell, a first connecting shaft connected to one side of the lower end of the connecting base, a cutting blade connected to one side of the outer wall of the first connecting shaft, a fixing block fixedly connected to one side of the outer wall of the lower end of the connecting base, a second connecting shaft movably connected to one side of the fixing block, a threaded groove formed on one side of the outer wall of the lower end of the fixing block, a limiting plate movably connected to one side of the outer wall of the second connecting shaft, a slot formed on the limiting plate, a connecting groove formed at the other end of the limiting plate, and a hand-tightening bolt movably connected to one side of the limiting plate. This utility model solves the problems of existing agricultural production devices having complex cutting blade fixing methods, often requiring multiple tools for disassembly and replacement, and some traditional devices lacking convenience and practicality in design, seriously affecting the progress of harvesting operations.

Methods to remove off-flavors and adverse aromas from hop-containing and / or cannabis-containing beverages and food products using Group 11 elements are described herein.

Provided is a proficiency testing material, and in more particular aspects, a cannabis proficiency testing material comprising: a plant substrate; and at least one chemical and / or microbial contaminant, wherein the at least one chemical and / or microbial contaminant is chemically or physically associated with the plant substrate. Methods of preparing the proficiency testing material and kits including the same are also provided. 20 26 20 48 88 24 J un 2 02 6 A B S T R A C T 2 0 2 6 2 0 4 8 8 8 2 4 J u n 2 0 2 6

A treatment method may include administering a first cannabinoid-based treatment to a first subject; receiving feedback from the first subject after the first cannabinoid-based treatment has been administered; adjusting the first cannabinoid-based treatment to provide a second cannabinoid-based treatment in response to the feedback; and administering the second cannabinoid-based treatment to the first subject. Systems, devices, and non-transient machine-readable storage media also are disclosed.

The present invention relates to a modified-release solid oral pharmaceutical composition, which is in the form of an enteric-coated capsule, wherein said capsule comprises cannabidiol (CBD), tetrahydrocannabinol (THC) and an emulsifier, and wherein the capsule optionally further comprises one or more cannabis terpenes. The solid oral pharmaceutical composition provided herein has a particularly advantageous modified release profile as well as an improved oral bioavailability as compared to conventional formulations of CBD and THC.

The present invention relates to improved method of treating breakthrough cancer pain. In particular the present invention relates to methods and devices for the treatment of breakthrough cancer pain through inhalation of tetrahydrocannabinol.

An adaptive cannabis product-manufacturing machine includes a first station configured to receive and transform a cannabis product from a first to a second state. One or more sensors measure a cannabis quantity-related characteristic (CQRC), such as cannabis level, mass, humidity, or flow behavior. A downstream cannabis-product transforming station includes an automatically adjustable adaptive mechanism that modifies its operation based on the CQRC, allowing consistent cannabis filling, compaction, closing, and end-forming despite variations in cannabis properties. A corresponding method is also provided.